title: Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.
abstract: OBJECTIVE
  The objective of this study was to reach a consensus on the minimum set of data that would allow to optimize the pharmacotherapy follow-up of patients on biologic agents for chronic systemic inflammatory conditions, through structured and standardized collection with an electronic tool in the hospital pharmacy.
  
  
  METHODS
  A scientific committee was formed (n = 5 hospital pharmacists). The Delphi Technique was used, 2 rounds of consultation by e-mail for hospital pharmacists. A structured questionnaire was used, based on a bibliographic review and recommendations by the scientific committee; 37 statements were assessed with the Likert 5-point scale (1= "Strongly Disagree"; 5= "Strongly Agree"). Consensus was reached when 75% or more of panel members assigned a score of 1-2 (rejection consensus) or 4-5 (agreement consensus) to the matter reviewed. Descriptive statistical analyses were conducted.
  
  
  RESULTS
  The study included 21 hospital pharmacists (70 were invited, there was 70% response). Consensus was reached for 100% of statements. The minimum set of data was agreed upon, as well as the recommendations that the pharmacist had to collect and make during visits: to document the health status, health-related quality of life, changes in treatment compliance and in patient autonomy, as well as the conditions to make feasible the systematic collection of the minimum data set.
  
  
  CONCLUSIONS
  There is consensus among hospital pharmacists about a minimum data set to be collected, through an electronic tool, which will order, standardize and structure the pharmacotherapy follow-up of patients with chronic inflammatory conditions on treatment with biologic agents in the spanish public health system.
authors.affiliation: Hospital Virgen de las Nieves, Granada.. mangel.calleja.sspa@juntadeandalucia.es.
authors.forename: Miguel Ángel
authors.initials: MÁ
authors.lastname: Calleja Hernández
authors.affiliation: Hospital Universitario La Paz, Madrid.. mangel.calleja.sspa@juntadeandalucia.es.
authors.forename: Alicia
authors.initials: A
authors.lastname: Herrero Ambrosio
authors.affiliation: Complejo Hospitalario Universitario de Santiago, Santiago de Compostela.. mangel.calleja.sspa@juntadeandalucia.es.
authors.forename: María Jesús
authors.initials: MJ
authors.lastname: Lamas Díaz
authors.affiliation: Hospital Universitario Vall d´Hebron, Barcelona.. mangel.calleja.sspa@juntadeandalucia.es.
authors.forename: Julio
authors.initials: J
authors.lastname: Martínez Cutillas
authors.affiliation: Hospital Universitario y Politécnico La Fe, Valencia.. mangel.calleja.sspa@juntadeandalucia.es.
authors.forename: Jose Luis
authors.initials: JL
authors.lastname: Poveda Andrés
authors.affiliation: Merck Sharp & Dohme.. mangel.calleja.sspa@juntadeandalucia.es.
authors.forename: Belén
authors.initials: B
authors.lastname: Aragón
mesh_terms: D001685:Biological Factors / Q000627:therapeutic use*; D002908:Chronic Disease; D032921:Consensus; D003625:Data Collection / Q000592:standards*; D003697:Delphi Technique; D057286:Electronic Health Records; D005500:Follow-Up Studies; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D010595:Pharmacists; D010607:Pharmacy Service, Hospital
chemical_list: D001685:Biological Factors